This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Our findings represent a significant advancement in clinical practice that can ultimately enhance patientcare." Gaurav Choudhary, Lead Principal Investigator, and Ruth and Paul Levinger Professor of Cardiology at the Alpert Medical School of Brown University.
milla1cf Fri, 05/10/2024 - 08:17 May 10, 2024 — With cardiovasculardisease being a leading cause of mortality worldwide, Vivalink , a leading provider of digital healthcare solutions, announces the launch of its comprehensive technology solution designed for Mobile Cardiac Telemetry (MCT) and Holter monitoring.
milla1cf Tue, 06/04/2024 - 20:54 June 4, 2024 — HeartFlow, a leader in cardiovascular healthcare technology, is pleased to announce a key Medicare policy development, which should allow for future expanded patient access to their Plaque Analysis product.
mtaschetta-millane Tue, 07/16/2024 - 09:59 July 16, 2024 — Arineta , a leader in advancing cardiovascular imaging solutions through cutting-edge technology, proudly announces the latest installation of its SpotLight Duo at Cardiovascular Consultants, Ltd. (CVC) CVC) in Arizona. sec per rotation.
Positron joins forces with the coalitions founding members, Bracco Diagnostics , CDL Nuclear Technologies and Siemens Healthcare who have come together to promote federal policies that advance health outcomes for patients with cardiovasculardisease and improve the availability of cardiac PET diagnostics throughout the United States.
Cardiovasculardisease (CVD) remains the leading cause of death in the U.S. trillion, placing an immense burden on both healthcare systems and patients. When we address heart disease only after a major event has occurred, weve already missed our greatest chance to control costs, and most importantly, save lives.
In its announcement about the workbook, ACC noted that cardiologists use digital devices and wearable technology to remotely monitor their patients for a variety of chronic cardiovasculardiseases, including heart failure, coronary artery disease, vascular disease and atrial fibrillation.
In a room of 20 people, it’s likely that about 10 of them, or half, will presently have some form of cardiovasculardisease (CVD). CVD is among the most prevalent diseases in the U.S., This includes artificial intelligence (AI), remote monitoring, virtual care, and other emerging technological advancements.
milla1cf Wed, 04/03/2024 - 18:58 April 3, 2024 — GE HealthCare announced the launch of Caption AI artificial intelligence (AI)-driven software for rapid cardiac assessments at the point of care on Vscan Air SL. The integration of Caption AI with the Vscan Air SL handheld ultrasound opens an entirely new chapter for cardiac screening.
Cardiovascular CT's non-invasive nature allows patients to avoid being admitted to a hospital for imaging, which makes it more convenient and patient-friendly. Committed to advancing patientcare, I introduced cardiac CT in my private practice, becoming the first private cardiologist in the region to do so.
Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.
Impacting 25 million people globally [1], deep venous disease results from venous thromboembolism, a condition that occurs when a blood clot forms in the vein [2]. It is the third most common cardiovasculardisease [2]. Deep venous anatomy and obstructions can present a multitude of complexities and mechanical challenges.
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study. Jennifer Currin, Ph.D.,
Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovasculardisease, and chronic kidney disease.
"These findings underscore the power of AI-ECG in identifying patients at a significantly higher risk of MACE and mortality, even when traditional markers like left ventricular ejection fraction appear normal. In our study, patients with a positive AI-ECG result had more than double the risk of MACE and a 65% higher risk of mortality.
In a world where technology reigns supreme, one of the most profound tools in medicine remains the irreplaceable electrocardiogram (ECG). This noninvasive method provides a graphical visualization of millivolt potentials received by electrodes located on the patient’s skin.
But as the new variants and their implications started showcasing in the infected patients, it became clear that it has several physiological manifestations. Among numerous other disorders, patients suffering from cardiovasculardiseases have the largest mortality rate.
Personalized treatment in cardiology has become a cornerstone of modern healthcare, allowing doctors to tailor interventions to each patient’s unique needs. Cardiovasculardiseases vary widely, so personalized care is critical for improving outcomes and patient satisfaction.
Here, we will delve into the fascinating evolution of ECG technology, exploring its origins, key milestones, and modern applications. Image source: sciencedirect.org Revolution of ECG for Better Cardiac Health Throughout the 20th century, significant milestones in electrocardiogram technology shaped its development and widespread adoption.
Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovasculardisease, type 2 diabetes, and metabolic syndrome. One promising strategy is the formation of creative partnerships between patients and their healthcare teams.
24 and how those may impact clinical practice and patientcare in this deep dive clinical trial session. Clinical and Investigative Horizons (Session 410) Sunday, April 7 4:30 – 5:45 p.m. ET Murphy Ballroom 4 ACC.24 24 planners note that attendees can gain insights from key clinical trials presented at ACC.24
Specialty Demand Certain specialties, focused on conditions like cardiovasculardisease and diabetes, also have rising demand, as the baby boomer population ages and becomes higher risk. The demand for cardiovascularcare, for example, continues to grow at an almost exponential rate. So what is the way forward?
World Heart Day World Heart Day was established by the World Heart Federation to raise awareness about cardiovasculardiseases (CVD) and promote heart-healthy lifestyles. Cardiovasculardiseases remain the leading cause of death globally.
Breaking Down the Process of Deep Learning Algorithms in Healthcare Healthcare, in general, faces challenges like cost reductions in prevention and treatment, low cost-effectiveness, overutilization, inadequate patientcare, and high readmission and mortality rates.
This blog will guide you through understanding the early signs of cardiac trouble, the importance of recognizing these signs early, and how GEMMS’ tailored EHR solutions enhance cardiology care. Unique Risk Factors for Women Women face unique risk factors for cardiovasculardisease.
milla1cf Fri, 05/17/2024 - 18:54 May 17, 2024 — Royal Philips , a global leader in health technology, is presenting new retrospective study results demonstrating the clinical and economic benefits of Philips’ AI-powered cardiac care solutions at the Heart Rhythm Annual Meeting in Boston (May 16-19).
The incidence of cardiovasculardisease is growing rapidly. According to WHO , cardiovasculardisease is the leading cause of death worldwide. What’s more, an increasing shortage of resources – physicians, as well as nurses – is escalating the vast backlog of cardiac care.
Electronic Health Record (EHR) software has an essential technology tool for cardiology clinics in meeting the ever-changing demands of the healthcare industry. EHRs offer a wide range of benefits, from improving patientcare to streamlining administrative tasks and ensuring payment.
There has been a tremendous upsurge in the number of patients suffering from cardiovasculardiseases in the recent few decades. The national registry reports play a vital role in collecting the data so that new methods can be innovated for the treatment of growing diseases. What is the Use of Registry Reports?
Parikh, MD Analysis “Although this data demonstrates the value of real-world data in the assessments of new technologies in which randomized data are not always available, there is still work that needs to be done to evaluate the current utilization of advanced therapies for PE in underrepresented patient populations,” said Sahil A.
With cardiovasculardisease affecting approximately 130 million people globally , according to the American Heart Association , the demand for timely cardiac diagnosis and access to consistent cardiac care is on the rise. Chair of the Department of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota.
With this collaboration, HeartFocus and Butterfly will unite ground-breaking technologies, and, once deployed, empower any healthcare professional to conduct medical-grade cardiac scans from anywhere, at any time.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content